Co-Diagnostics Current Ratio 2017-2024 | CODX

Co-Diagnostics current ratio from 2017 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Co-Diagnostics Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2024-12-31 $0.03B $0.01B 4.41
2024-09-30 $0.04B $0.01B 6.92
2024-06-30 $0.05B $0.01B 9.09
2024-03-31 $0.05B $0.01B 10.19
2023-12-31 $0.06B $0.01B 10.81
2023-09-30 $0.07B $0.01B 13.99
2023-06-30 $0.08B $0.01B 15.13
2023-03-31 $0.09B $0.00B 23.80
2022-12-31 $0.09B $0.00B 23.94
2022-09-30 $0.10B $0.01B 16.95
2022-06-30 $0.12B $0.01B 17.06
2022-03-31 $0.13B $0.01B 9.63
2021-12-31 $0.12B $0.01B 9.14
2021-09-30 $0.10B $0.00B 24.83
2021-06-30 $0.09B $0.01B 19.10
2021-03-31 $0.08B $0.00B 18.38
2020-12-31 $0.07B $0.00B 16.69
2020-09-30 $0.05B $0.00B 28.63
2020-06-30 $0.04B $0.00B 12.36
2020-03-31 $0.02B $0.00B 16.43
2019-12-31 $0.00B $0.00B 4.83
2019-09-30 $0.00B $0.00B 10.02
2019-06-30 $0.01B $0.00B 14.61
2019-03-31 $0.01B $0.00B 16.53
2018-12-31 $0.00B $0.00B 0.45
2018-09-30 $0.00B $0.00B 1.09
2018-06-30 $0.00B $0.00B 6.13
2018-03-31 $0.00B $0.00B 10.98
2017-12-31 $0.00B $0.00B 7.09
2017-09-30 $0.01B $0.00B 8.73
2017-06-30 $0.00B $0.01B 0.07
2017-03-31 $0.00B 0.00
2016-12-31 $0.00B 0.00
2016-09-30 $0.00B 0.00
2016-06-30 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical Services $0.011B $0.004B
Co-Diagnostics Inc. is a molecular diagnostics company. It develops, manufactures and markets a new, state-of-the-art diagnostics technology. The Company's technology is utilized for tests which are designed using the detection and/or analysis of nucleic acid molecules. It also uses proprietary technology to design specific tests to locate genetic markers for use in industries other than infectious disease and license the use of those tests to specific customers. Co-Diagnostics Inc. is based in UT, United States.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $135.784B 25.47
Elevance Health (ELV) United States $91.409B 11.80
CVS Health (CVS) United States $84.718B 10.53
Cencora (COR) United States $54.879B 19.08
DiDi Global (DIDIY) China $20.661B 31.36
Natera (NTRA) United States $20.542B 0.00
BioMerieux (BMXMF) France $15.263B 0.00
Solventum (SOLV) United States $12.150B 12.86
EUROFINS SCIENT (ERFSF) Luxembourg $11.973B 0.00
Doximity (DOCS) United States $11.050B 57.47
CochLear (CHEOY) Australia $10.944B 0.00
ICON (ICLR) Ireland $10.818B 10.06
Revvity (RVTY) United States $10.756B 18.51
Viatris (VTRS) United States $10.293B 3.54
Medpace Holdings (MEDP) United States $8.508B 22.60
Sonic Healthcare (SKHHY) Australia $8.280B 0.00
Avantor (AVTR) United States $8.191B 11.90
HealthEquity (HQY) United States $7.819B 38.47
Charles River Laboratories (CRL) United States $6.817B 13.36
Amplifon S.p.A (AMFPF) Italy $4.966B 26.21
Bausch + Lomb (BLCO) Canada $3.982B 23.48
BrightSpring Health Services (BTSG) United States $3.976B 36.81
Sotera Health (SHC) United States $3.727B 21.18
Alignment Healthcare (ALHC) United States $2.991B 0.00
Surgery Partners (SGRY) United States $2.841B 32.59
Concentras Parent (CON) United States $2.743B 15.85
Organon (OGN) United States $2.264B 2.41
Premier (PINC) United States $2.106B 14.42
Ardent Health Partners (ARDT) United States $2.077B 8.85
Progyny (PGNY) United States $1.815B 39.98
GeneDx Holdings (WGS) United States $1.687B 64.99
GoodRx Holdings (GDRX) United States $1.657B 30.86
PACS (PACS) United States $1.590B 0.00
Pediatrix Medical (MD) United States $1.248B 9.50
Teladoc Health (TDOC) United States $1.247B 0.00
Agilon Health (AGL) United States $1.196B 0.00
Ryman Healthcare (RYHTY) New Zealand $1.039B 0.00
Establishment Labs Holdings (ESTA) $0.978B 0.00
CareDx (CDNA) United States $0.855B 13.36
AMN Healthcare Services Inc (AMN) United States $0.840B 7.89
Embecta (EMBC) United States $0.696B 4.71
QDM (QDMI) Hong Kong, SAR China $0.690B 0.00
Nutex Health (NUTX) United States $0.667B 13.08
Enhabit (EHAB) United States $0.521B 42.83
Auna S.A (AUNA) Luxembourg $0.508B 13.45
InnovAge Holding (INNV) United States $0.491B 0.00
Sonida Senior Living (SNDA) United States $0.466B 0.00
LifeMD (LFMD) United States $0.375B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.352B 0.00
SBC Medicals (SBC) United States $0.345B 0.00
Beauty Health (SKIN) United States $0.234B 0.00
Oncology Institute (TOI) United States $0.212B 0.00
Performant Healthcare (PHLT) United States $0.195B 0.00
DocGo (DCGO) United States $0.143B 23.33
Basel Medical Group (BMGL) Singapore $0.088B 0.00
So-Young (SY) China $0.086B 0.00
Sera Prognostics (SERA) United States $0.084B 0.00
OncoCyte (OCX) United States $0.082B 0.00
Ascend Wellness Holdings (AAWH) United States $0.076B 0.00
NeueHealth (NEUE) United States $0.060B 0.00
IceCure Medical (ICCM) Israel $0.057B 0.00
Biodesix (BDSX) United States $0.054B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.029B 0.00
Pheton Holdings (PTHL) China $0.029B 0.00
KindlyMD (KDLY) United States $0.023B 0.00
ModivCare (MODV) United States $0.017B 0.00
SeaStar Medical Holding (ICU) United States $0.012B 0.00
Intelligent Bio Solutions (INBS) United States $0.008B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00